May 10, 2024 — How an individual’s immune system responds to the bacteria that causes tuberculosis (TB)—and therefore whether they develop the disease—may differ across age and sex, according to a new study co-led by Harvard T.H. Chan School of Public Health’s Sarah Fortune.

Boston, MA, December 8, 2022 – Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis (Mtb) to survive antibiotic treatment. The study, led by Harvard T.H. Chan School of Public Health, could help inform future therapeutics and reduce treatment failure in tuberculosis patients.

May 12, 2022 – Over the past few years of his PhD research, Harim Won has been laying the groundwork to develop a new type of antibiotic to treat tuberculosis (TB), addressing the long-standing problems of lengthy treatments and antibiotic resistance. Won is using a new approach to turn a normal protein system in the bacterial cell against itself.